Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased platelet aggregates in patients with transient ischemic attacks.

K K Wu, J C Hoak

    Stroke
    |September 1, 1975
    PubMed
    Summary

    Platelet aggregates are implicated in cerebrovascular disease, with lower ratios observed in transient ischemic attack (TIA) patients. Antiplatelet therapy can normalize these ratios, suggesting their role in disease pathogenesis and guiding treatment selection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Clinical study on the efficacy and safety of glaucoma drainage implants in the treatment of different types of glaucoma].

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2024
    Same author

    Posttraumatic Stress, Anxiety, and Depression in COVID-19 Survivors.

    East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2022
    Same author

    Patients' Reports of Traumatic Experience and Posttraumatic Stress in Psychiatric Settings.

    East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2020
    Same author

    First Report of Paulownia Witches'-Broom Phytoplasma in China.

    Plant disease·2019
    Same author

    First Report of a 16SrI-C Group Phytoplasma Associated With a Yellows-Type Disease Affecting Willow Plants in China.

    Plant disease·2019
    Same author

    [A multicenter clinical study on 1 138 cases of invasive pneumococcal disease in children from 2012 to 2017].

    Zhonghua er ke za zhi = Chinese journal of pediatrics·2018

    Area of Science:

    • Neurology
    • Hematology
    • Vascular Biology

    Background:

    • Platelet aggregates are increasingly recognized for their potential role in cerebrovascular disease pathogenesis.
    • Understanding the pathogenetic significance of platelet aggregates is crucial for developing effective therapeutic strategies.

    Purpose of the Study:

    • To evaluate the pathogenetic importance of platelet aggregates in patients experiencing transient ischemic attacks (TIAs).
    • To assess the utility of platelet aggregate determination in guiding antiplatelet therapy selection for cerebrovascular insufficiency.

    Main Methods:

    • A platelet count ratio method was employed to study 66 patients with TIAs.
    • Control groups included 30 healthy subjects and 22 patients without thromboembolic disorders.
    • Treatment efficacy was assessed using aspirin, dipyridamole, and sulfinpyrazone, monitoring platelet aggregate ratios.

    Related Experiment Videos

    Main Results:

    • The mean platelet aggregate ratio was significantly lower in the TIA group (0.75 +/- 0.03 SEM) compared to normal (0.90 +/- 0.02) and patient controls (0.88 +/- 0.01) (P < 0.01).
    • Antiplatelet therapy (aspirin and dipyridamole) normalized platelet aggregate ratios in 13 out of 17 treated TIA patients.
    • One patient responded to sulfinpyrazone after failing other treatments, with symptom recurrence linked to increased platelet aggregates upon drug discontinuation.

    Conclusions:

    • Platelet aggregates appear to play a significant role in the pathogenesis of cerebrovascular insufficiency.
    • Measuring platelet aggregates is a valuable method for identifying patients who may benefit from specific antiplatelet therapies.